Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, October 17, 2022
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
Joseph Schwartz Maintained (SRPT) at Buy with Increased Target to $145 on, Oct 17th, 2022
Joseph Schwartz of SVB Leerink, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Increased Target from $126 to $145 on, Oct 17th, 2022.
Joseph has made no other calls on SRPT in the last 4 months.
There are 6 other peers that have a rating on SRPT. Out of the 6 peers that are also analyzing SRPT, 2 agree with Joseph's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $141 on, Thursday, October 13th, 2022
- Judah Frommer of "Credit Suisse" Maintained at Hold with Increased Target to $93 on, Wednesday, August 3rd, 2022
These are the ratings of the 4 analyists that currently disagree with Joseph
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $124 on, Thursday, August 18th, 2022
- Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $182 on, Tuesday, August 9th, 2022
- Gil Blum of "Needham" Maintained at Strong Buy with Increased Target to $162 on, Friday, July 29th, 2022
- Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $128 on, Friday, June 24th, 2022
